European Business Development Conference 2017 / 10 to 11 October 2017 / Heidelberg

The European Business Development Conference (EBDC) - a special networking event for decision makers from Biotech, Pharma and the Investment sector - will take place on 10 and 11 October 2017 in Heidelberg, Germany.

Companies located in the Technologiepark receive discounts in all ticket categories:

  • Participation 545, - € (instead of 985, - € / 45% savings)
  • Participation plus company presentation 1.095, - € (instead of 1.975, - € / 45% savings)
  • Participation of additional company representatives 390, - € (instead of 830, - € / 53% savings)
    (All prices excl. VAT)

The EBDC is a two-day meeting that aims to bring a selected group of 120 business development executives from international pharmaceutical corporations and European biotech companies together with representatives from private equity and venture capital companies.

A sophisticated line-up of international speakers in four sessions will be focusing on the newest trends in therapeutic development. The EBCD programme also includes company presentations from innovative biotechs and of course provides conference partnering again.

Among the keynote speakers will be Christoph Hüls (Head of Merck Group Innovation Strategy, Chief Innovation Officer) and Paola Casarosa (Corporate Vice President for Business Development and Licensing at Boehringer Ingelheim), who will introduce two sophisticated conference days.

The two-day programme offers symposia on “Advances in Oncology”, “Financing and Business Development for Pharma and Biotech” and “Immunology and Inflammation – How to fight the Rise of Autoimmune Disorders”, company presentations and start-up pitches in collaboration with Science4Life. There will be further speakers from AbbVie, Almirall, Amgen, BaseLaunch, Boehringer Ingelheim, EMBL Ventures, EY, Menarini, Merck, Nextech Invest, Selvita, Teva und UCB and more.

A great and well-established format to get the attention of these players are company presentations. Companies can apply for such a presentation. More than 120 experts will give their full attention to your 15 min pitch (including 5 min for Q&A). Please apply for company presentation by registering online to the EBDC. Companies located in the technology park receive reduced terms!

The Heidelberg Biotech Cluster is one of the most important medical hubs in Germany; a place where startups, small businesses, major research facilities and global players collaborate, from research and development to production; Technologiepark Heidelberg is our partner for this event.

Further information and registration EBDC 2017 

10.10.2017 - 10:15